Hot Natural Products & Bioactive Compounds

BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.

Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.

Hot Products from BioCrick

Showing 5057 - 5064 of 9359 hot products

BioCrick hot natural products and bioactive compounds
Catalog No. Product Name
BCN3068 Desoxygambogenin
1. Desoxygambogenin has anti-HIV-1 activity.
2. Desoxygambogenin is a cytotoxic xanthone.
BCN3069 Gambogin
1. Gambogin is a cytotoxic xanthone.
BCN3071 Gaudichaudic acid
1. Gaudichaudic acid shows cytotoxicities against human leukemia K562 (K562/S) and doxorubicin-resistant K562 (K562/R) cell lines, and shows similar inhibitory effects on both cell lines.
BCN3073 Morellic acid
1. Morellic acid has cytotoxic activity.
2. Morellic acid has anti-HIV-1 activity.
3. Morellic acid has antibacterial activity.
BCN3074 Isomorellic acid
1. Isomorellic acid is a cytotoxic caged xanthone.
BCN3075 Isomorellinol
1. Isomorellinol induces apoptosis in cholangiocarcinoma (CCA)cells which is mediated through a mitochondria-dependent signaling pathway.
BCN3076 Isogambogenic acid
1. Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy.
2. Isogambogenic acid exhibits an anticancer effect by inducing autophagy-dependent cell death in NSCLC cells, which may be an effective chemotherapeutic agent that can be used against NSCLC in a clinical setting.
BCN3077 Gambogenic acid
Gambogenic acid is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects, it can cause aberrant autophagy to induce cell death and may suggest the potential application of Gambogenic acid as a tool or viable drug in anticancer therapies.Gambogenic acid could inhibit the proliferation of melanoma B16 cells and induce their apoptosis within certain time and concentration ranges. Its mechanism in inducing the cell apoptosis may be related to PI3K/Akt/mTOR signaling pathways.